Globus Medical (GMED) — Capital Reinvestment Ratio

Latest as of March 2026: 0.20x

Globus Medical (GMED) has a Capital Reinvestment Ratio of 0.20x as of March 2026, meaning it reinvests 0% of its operating cash flow ($202.36 Million) in capital expenditures ($39.62 Million). See free cash flow generation of Globus Medical to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.20x
Capex / Operating Cash Flow

Operating Cash Flow

$202.36 Million
USD

Capital Expenditures

$39.62 Million
USD

Data as of

Mar 2026
Most recent filing

Globus Medical Capital Reinvestment Ratio (2009–2025)

This chart tracks Globus Medical's Capital Reinvestment Ratio across 17 annual periods.

Annual Capital Reinvestment Ratio for Globus Medical (2009–2025)

Year-by-year Capital Reinvestment Ratio for Globus Medical from 2009 to 2025. For live market cap and broader valuation context, see market value of Globus Medical.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.22x $753.45 Million $164.68 Million ▼ -1.4%
2024 0.22x $520.64 Million $115.43 Million ▼ -31.0%
2023 0.32x $243.50 Million $78.27 Million ▼ -22.5%
2022 0.41x $178.47 Million $74.05 Million ▲ +101.5%
2021 0.21x $276.27 Million $56.90 Million ▼ -35.7%
2020 0.32x $198.79 Million $63.66 Million ▼ -22.2%
2019 0.41x $171.97 Million $70.75 Million ▲ +25.2%
2018 0.33x $181.64 Million $59.70 Million ▲ +2.2%
2017 0.32x $159.53 Million $51.30 Million ▲ +35.1%
2016 0.24x $171.89 Million $40.91 Million ▼ -42.8%
2015 0.42x $121.96 Million $50.76 Million ▲ +33.1%
2014 0.31x $79.17 Million $24.75 Million ▲ +23.4%
2013 0.25x $93.47 Million $23.68 Million ▼ -21.5%
2012 0.32x $76.52 Million $24.68 Million ▲ +9.6%
2011 0.29x $76.41 Million $22.49 Million ▲ +70.5%
2010 0.17x $71.29 Million $12.30 Million ▼ -78.7%
2009 0.81x $32.08 Million $25.96 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow